{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Signal", "transduction", "abnormalities", "in", "T", "lymphocytes", "from", "patients", "with", "advanced", "renal", "carcinoma", ":", "clinical", "relevance", "and", "effects", "of", "cytokine", "therapy", "."], "sentence": "Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma : clinical relevance and effects of cytokine therapy .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Studies", "have", "demonstrated", "abnormalities", "of", "the", "CD3", "/", "T-cell", "antigen", "receptor", "(", "TCR", ")", "and", "pathways", "of", "signal", "transduction", "in", "T", "lymphocytes", "from", "animals", "and", "patients", "with", "advanced", "malignancy", "."], "sentence": "Studies have demonstrated abnormalities of the CD3 / T-cell antigen receptor ( TCR ) and pathways of signal transduction in T lymphocytes from animals and patients with advanced malignancy .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "S3", "tokens": ["Diminished", "expression", "of", "TCRzeta", "and", "p56(lck)", "that", "are", "associated", "with", "the", "TCR", "and", "reduced", "nuclear", "localization", "of", "RelA", "containing", "nuclear", "factor", "kappaB", "(", "NFkappaB", ")", "complexes", "have", "been", "noted", "."], "sentence": "Diminished expression of TCRzeta and p56(lck) that are associated with the TCR and reduced nuclear localization of RelA containing nuclear factor kappaB ( NFkappaB ) complexes have been noted .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "Diminished", "start": 0, "end": 0}, "arguments": [{"entity_id": "T30", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "Diminished", "start": 0, "end": 0}, "arguments": [{"entity_id": "T30", "text": "expression", "role": "Theme"}]}, {"id": "E3", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 1, "end": 1}, "arguments": [{"entity_id": "T1", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 1, "end": 1}, "arguments": [{"entity_id": "T2", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E5", "event_type": "Binding", "trigger": {"text": "associated", "start": 8, "end": 8}, "arguments": [{"entity_id": "T2", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E6", "event_type": "Binding", "trigger": {"text": "associated", "start": 8, "end": 8}, "arguments": [{"entity_id": "T1", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 13, "end": 13}, "arguments": [{"entity_id": "T34", "text": "localization", "role": "Theme"}]}, {"id": "E8", "event_type": "Localization", "trigger": {"text": "localization", "start": 15, "end": 15}, "arguments": [{"entity_id": "T3", "text": "RelA", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "TCRzeta", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T2", "text": "p56(lck)", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T3", "text": "RelA", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T29", "text": "Diminished", "entity_type": "Negative_regulation", "start": 0, "end": 0}, {"id": "T30", "text": "expression", "entity_type": "Gene_expression", "start": 1, "end": 1}, {"id": "T31", "text": "associated", "entity_type": "Binding", "start": 8, "end": 8}, {"id": "T32", "text": "reduced", "entity_type": "Negative_regulation", "start": 13, "end": 13}, {"id": "T34", "text": "localization", "entity_type": "Localization", "start": 15, "end": 15}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["These", "defects", "have", "been", "described", "in", "T", "cells", "from", "patients", "with", "malignant", "melanoma", ",", "renal", "cell", "carcinoma", "(", "RCC", ")", ",", "ovarian", "cancer", ",", "and", "colorectal", "cancer", "."], "sentence": "These defects have been described in T cells from patients with malignant melanoma , renal cell carcinoma ( RCC ) , ovarian cancer , and colorectal cancer .", "event_mentions": [], "entity_mentions": [{"id": "T35", "text": "defects", "entity_type": "Negative_regulation", "start": 1, "end": 1}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Preliminary", "observations", "also", "indicate", "possible", "correlation", "with", "clinical", "variables", "such", "as", "stage", "in", "selected", "instances", "."], "sentence": "Preliminary observations also indicate possible correlation with clinical variables such as stage in selected instances .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "S6", "tokens": ["To", "further", "characterize", "altered", "expression", "of", "TCRzeta", ",", "p56(lck)", ",", "and", "impaired", "activation", "of", "NFkappaB", ",", "T", "lymphocytes", "were", "obtained", "from", "65", "patients", "with", "RCC", ",", "the", "majority", "of", "whom", "were", "receiving", "combination", "cytokine", "therapy", "[", "interleukin", "(IL)-2", ",", "IFN", "alpha", "-", "containing", "regimens", "]", "and", "37", "control", "individuals", "."], "sentence": "To further characterize altered expression of TCRzeta , p56(lck) , and impaired activation of NFkappaB , T lymphocytes were obtained from 65 patients with RCC , the majority of whom were receiving combination cytokine therapy [ interleukin (IL)-2 , IFN alpha - containing regimens ] and 37 control individuals .", "event_mentions": [{"id": "E12", "event_type": "Negative_regulation", "trigger": {"text": "altered", "start": 3, "end": 3}, "arguments": [{"entity_id": "T37", "text": "expression", "role": "Theme"}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "altered", "start": 3, "end": 3}, "arguments": [{"entity_id": "T37", "text": "expression", "role": "Theme"}]}, {"id": "E14", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 4, "end": 4}, "arguments": [{"entity_id": "T4", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 4, "end": 4}, "arguments": [{"entity_id": "T5", "text": "p56(lck)", "role": "Theme"}]}], "entity_mentions": [{"id": "T4", "text": "TCRzeta", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T5", "text": "p56(lck)", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T6", "text": "interleukin (IL)-2", "entity_type": "Protein", "start": 36, "end": 37}, {"id": "T7", "text": "IFN alpha", "entity_type": "Protein", "start": 39, "end": 40}, {"id": "T36", "text": "altered", "entity_type": "Negative_regulation", "start": 3, "end": 3}, {"id": "T37", "text": "expression", "entity_type": "Gene_expression", "start": 4, "end": 4}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S7", "tokens": ["In", "29", "of", "these", "patients", ",", "levels", "of", "TCRzeta", "and", "p56(lck)", "were", "determined", "by", "Western", "blots", "of", "T-cell", "lysates", "and", "semiquantitated", "using", "densitometry", "."], "sentence": "In 29 of these patients , levels of TCRzeta and p56(lck) were determined by Western blots of T-cell lysates and semiquantitated using densitometry .", "event_mentions": [{"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "levels", "start": 6, "end": 6}, "arguments": [{"entity_id": "T9", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E17", "event_type": "Gene_expression", "trigger": {"text": "levels", "start": 6, "end": 6}, "arguments": [{"entity_id": "T8", "text": "TCRzeta", "role": "Theme"}]}], "entity_mentions": [{"id": "T8", "text": "TCRzeta", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T9", "text": "p56(lck)", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T38", "text": "levels", "entity_type": "Gene_expression", "start": 6, "end": 6}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Relative", "levels", "were", "then", "correlated", "with", "a", "series", "of", "clinical", "variables", "including", "response", "to", "therapy", ",", "performance", "status", ",", "survival", ",", "disease", "sites", ",", "age", ",", "and", "others", "."], "sentence": "Relative levels were then correlated with a series of clinical variables including response to therapy , performance status , survival , disease sites , age , and others .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["In", "another", "group", "of", "28", "patients", "(", "three", "individuals", "from", "the", "first", "group", ")", ",", "the", "frequency", "of", "abnormal", "NFkappaB", "activation", "was", "studied", "using", "electrophoretic", "mobility", "shift", "assays", "after", "activation", "of", "T", "cells", "with", "phorbol", "myristate", "acetate", "/", "ionomycin", "or", "anti-CD3", "monoclonal", "antibody", "."], "sentence": "In another group of 28 patients ( three individuals from the first group ) , the frequency of abnormal NFkappaB activation was studied using electrophoretic mobility shift assays after activation of T cells with phorbol myristate acetate / ionomycin or anti-CD3 monoclonal antibody .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Changes", "in", "these", "signaling", "molecules", "during", "cytokine", "treatment", "were", "also", "investigated", "."], "sentence": "Changes in these signaling molecules during cytokine treatment were also investigated .", "event_mentions": [], "entity_mentions": [{"id": "T39", "text": "Changes", "entity_type": "Positive_regulation", "start": 0, "end": 0}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S11", "tokens": ["TCRzeta", "and", "p56(lck)", "were", "detected", "in", "the", "peripheral", "blood", "T", "cells", "in", "27", "of", "29", "patients", ",", "and", "overall", ",", "reduced", "levels", "were", "noted", "visually", "in", "12", "of", "29", "(", "41", "%", ")", "and", "13", "of", "29", "(", "45", "%", ")", "individuals", ",", "respectively", "."], "sentence": "TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall , reduced levels were noted visually in 12 of 29 ( 41 % ) and 13 of 29 ( 45 % ) individuals , respectively .", "event_mentions": [{"id": "E20", "event_type": "Gene_expression", "trigger": {"text": "detected", "start": 4, "end": 4}, "arguments": [{"entity_id": "T10", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E21", "event_type": "Gene_expression", "trigger": {"text": "detected", "start": 4, "end": 4}, "arguments": [{"entity_id": "T11", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E22", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 20, "end": 20}, "arguments": [{"entity_id": "T40", "text": "detected", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "TCRzeta", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T11", "text": "p56(lck)", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T40", "text": "detected", "entity_type": "Gene_expression", "start": 4, "end": 4}, {"id": "T41", "text": "reduced", "entity_type": "Negative_regulation", "start": 20, "end": 20}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S12", "tokens": ["When", "levels", "were", "semiquantitated", "using", "densitometry", ",", "significant", "decreases", "of", "TCRzeta", "(", "P", "=", "0.029", ")", "and", "p56(lck)", "(", "P", "=", "0.029", ")", "but", "not", "CD3epsilon", "(", "P", "=", "0.131", ")", ",", "compared", "with", "control", "levels", ",", "were", "found", "."], "sentence": "When levels were semiquantitated using densitometry , significant decreases of TCRzeta ( P = 0.029 ) and p56(lck) ( P = 0.029 ) but not CD3epsilon ( P = 0.131 ) , compared with control levels , were found .", "event_mentions": [{"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "decreases", "start": 8, "end": 8}, "arguments": [{"entity_id": "T14", "text": "CD3epsilon", "role": "Theme"}]}, {"id": "E24", "event_type": "Negative_regulation", "trigger": {"text": "decreases", "start": 8, "end": 8}, "arguments": [{"entity_id": "T13", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E25", "event_type": "Negative_regulation", "trigger": {"text": "decreases", "start": 8, "end": 8}, "arguments": [{"entity_id": "T12", "text": "TCRzeta", "role": "Theme"}]}], "entity_mentions": [{"id": "T12", "text": "TCRzeta", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T13", "text": "p56(lck)", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T14", "text": "CD3epsilon", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T42", "text": "decreases", "entity_type": "Negative_regulation", "start": 8, "end": 8}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S13", "tokens": ["In", "patients", "treated", "with", "IL-2", "/", "IFN", "alpha", "-", "based", "therapy", ",", "relative", "levels", "of", "TCRzeta", "increased", "significantly", "(", "P", "=", "0.002", ")", "on", "day", "15", "of", "cycle", "one", "compared", "with", "the", "baseline", "."], "sentence": "In patients treated with IL-2 / IFN alpha - based therapy , relative levels of TCRzeta increased significantly ( P = 0.002 ) on day 15 of cycle one compared with the baseline .", "event_mentions": [{"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 16, "end": 16}, "arguments": [{"entity_id": "T17", "text": "TCRzeta", "role": "Theme"}]}], "entity_mentions": [{"id": "T15", "text": "IL-2", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T16", "text": "IFN alpha", "entity_type": "Protein", "start": 6, "end": 7}, {"id": "T17", "text": "TCRzeta", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T43", "text": "increased", "entity_type": "Positive_regulation", "start": 16, "end": 16}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S14", "tokens": ["Correlations", "of", "TCRzeta", "or", "p56(lck)", "levels", "with", "response", "or", "disease", "variables", ",", "except", "for", "lower", "TCRzeta", "levels", "(", "P", "<", "0.001", ")", "in", "the", "presence", "of", "bone", "metastases", ",", "were", "not", "found", "."], "sentence": "Correlations of TCRzeta or p56(lck) levels with response or disease variables , except for lower TCRzeta levels ( P < 0.001 ) in the presence of bone metastases , were not found .", "event_mentions": [{"id": "E27", "event_type": "Negative_regulation", "trigger": {"text": "lower", "start": 14, "end": 14}, "arguments": [{"entity_id": "T20", "text": "TCRzeta", "role": "Theme"}]}], "entity_mentions": [{"id": "T18", "text": "TCRzeta", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T19", "text": "p56(lck)", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T20", "text": "TCRzeta", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T44", "text": "lower", "entity_type": "Negative_regulation", "start": 14, "end": 14}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Abnormal", "NFkappaB", "activation", "after", "stimulation", "with", "phorbol", "myristate", "acetate", "/", "ionomycin", "and", "/", "or", "anti-CD3", "monoclonal", "antibody", "was", "found", "in", "59", "%", "of", "patients", "(", "17", "of", "28", ")", "and", "was", "not", "accounted", "for", "by", "the", "advanced", "age", "of", "the", "study", "cohort", "."], "sentence": "Abnormal NFkappaB activation after stimulation with phorbol myristate acetate / ionomycin and / or anti-CD3 monoclonal antibody was found in 59 % of patients ( 17 of 28 ) and was not accounted for by the advanced age of the study cohort .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["Activation", "of", "NFkappaB", "in", "peripheral", "blood", "T", "cells", "was", "inducible", "during", "cytokine", "therapy", "in", "four", "of", "six", "individuals", "who", "displayed", "impaired", "NFkappaB", "activity", "prior", "to", "therapy", "."], "sentence": "Activation of NFkappaB in peripheral blood T cells was inducible during cytokine therapy in four of six individuals who displayed impaired NFkappaB activity prior to therapy .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9796963.txt", "sent_id": "S17", "tokens": ["Moreover", ",", "impaired", "activation", "of", "NFkappaB", "does", "not", "appear", "linked", "to", "a", "reduction", "of", "TCRzeta", "expression", ",", "because", "in", "five", "patients", ",", "normal", "TCRzeta", "levels", "were", "present", "although", "kappaB", "binding", "was", "not", "inducible", "."], "sentence": "Moreover , impaired activation of NFkappaB does not appear linked to a reduction of TCRzeta expression , because in five patients , normal TCRzeta levels were present although kappaB binding was not inducible .", "event_mentions": [{"id": "E28", "event_type": "Negative_regulation", "trigger": {"text": "reduction", "start": 12, "end": 12}, "arguments": [{"entity_id": "T46", "text": "expression", "role": "Theme"}]}, {"id": "E29", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 15, "end": 15}, "arguments": [{"entity_id": "T21", "text": "TCRzeta", "role": "Theme"}]}], "entity_mentions": [{"id": "T21", "text": "TCRzeta", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T22", "text": "TCRzeta", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T45", "text": "reduction", "entity_type": "Negative_regulation", "start": 12, "end": 12}, {"id": "T46", "text": "expression", "entity_type": "Gene_expression", "start": 15, "end": 15}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S18", "tokens": ["In", "the", "majority", "of", "patients", "with", "advanced", "RCC", ",", "peripheral", "blood", "T", "cells", "express", "TCRzeta", "and", "p56(lck)", ",", "and", "in", "a", "subset", ",", "reduced", "levels", "of", "these", "TCRzeta", "associated", "molecules", "are", "seen", "that", "may", "increase", "during", "cytokine-based", "therapy", "."], "sentence": "In the majority of patients with advanced RCC , peripheral blood T cells express TCRzeta and p56(lck) , and in a subset , reduced levels of these TCRzeta associated molecules are seen that may increase during cytokine-based therapy .", "event_mentions": [{"id": "E30", "event_type": "Gene_expression", "trigger": {"text": "express", "start": 13, "end": 13}, "arguments": [{"entity_id": "T24", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E31", "event_type": "Gene_expression", "trigger": {"text": "express", "start": 13, "end": 13}, "arguments": [{"entity_id": "T23", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E32", "event_type": "Negative_regulation", "trigger": {"text": "reduced levels", "start": 23, "end": 24}, "arguments": [{"entity_id": "T23", "text": "TCRzeta", "role": "Theme"}]}, {"id": "E33", "event_type": "Negative_regulation", "trigger": {"text": "reduced levels", "start": 23, "end": 24}, "arguments": [{"entity_id": "T24", "text": "p56(lck)", "role": "Theme"}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 34, "end": 34}, "arguments": [{"entity_id": "T48", "text": "reduced levels", "role": "Theme"}]}, {"id": "E35", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 34, "end": 34}, "arguments": [{"entity_id": "T48", "text": "reduced levels", "role": "Theme"}]}], "entity_mentions": [{"id": "T23", "text": "TCRzeta", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T24", "text": "p56(lck)", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T25", "text": "TCRzeta", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T47", "text": "express", "entity_type": "Gene_expression", "start": 13, "end": 13}, {"id": "T48", "text": "reduced levels", "entity_type": "Negative_regulation", "start": 23, "end": 24}, {"id": "T49", "text": "increase", "entity_type": "Positive_regulation", "start": 34, "end": 34}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S19", "tokens": ["Abnormal", "activation", "of", "NFkappaB", "is", "also", "present", "in", ">", "50", "%", "of", "patients", "and", "may", "also", "revert", "to", "normal", "during", "IL-2", "/", "I", "FN", "alpha", "-", "based", "treatment", "."], "sentence": "Abnormal activation of NFkappaB is also present in > 50 % of patients and may also revert to normal during IL-2 / I FN alpha - based treatment .", "event_mentions": [], "entity_mentions": [{"id": "T26", "text": "IL-2", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T27", "text": "FN alpha", "entity_type": "Protein", "start": 23, "end": 24}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "S20", "tokens": ["This", "alteration", "in", "NFkappaB", "activation", "occurred", "in", "the", "presence", "of", "normal", "expression", "of", "TCRzeta", "-", "associated", "signaling", "elements", "."], "sentence": "This alteration in NFkappaB activation occurred in the presence of normal expression of TCRzeta - associated signaling elements .", "event_mentions": [], "entity_mentions": [{"id": "T28", "text": "TCRzeta", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMID-9796963.txt", "sent_id": "", "tokens": ["The", "clinical", "significance", "of", "these", "findings", "remains", "unclear", "."], "sentence": "The clinical significance of these findings remains unclear .", "event_mentions": [], "entity_mentions": []}
